Last reviewed · How we verify

NCT05503056

Art Therapy in Obstetric Patients

Completed NA Last updated 17 April 2024
What this trial tests

NA trial testing art therapy in Pregnancy Related in 100 participants. Completed in 13 April 2024.

Timeline
1 September 2022
Primary endpoint
30 August 2023
13 April 2024

Quick facts

Lead sponsorMedstar Health Research Institute
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment100
Start date1 September 2022
Primary completion30 August 2023
Estimated completion13 April 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Medstar Health Research Institute

Who can join

18 and older, female only, with Pregnancy Related or Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective study examining the potential impact art therapy has on postpartum depression and mother-baby bonding in women. Women who receive care at Washington Hospital Center's will be recruited for this study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of art therapy

Trials testing the same drug.

Other recruiting trials for Pregnancy Related

Currently open trials in the same condition.

Other Medstar Health Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05503056.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing